These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 16505974)
41. Unveiling the modulation of Nogo receptor in neuroregeneration and plasticity: Novel aspects and future horizon in a new frontier. Dave BP; Shah KC; Shah MB; Chorawala MR; Patel VN; Shah PA; Shah GB; Dhameliya TM Biochem Pharmacol; 2023 Apr; 210():115461. PubMed ID: 36828272 [TBL] [Abstract][Full Text] [Related]
42. Origin of Nogo-A by domain shuffling in an early jawed vertebrate. Shypitsyna A; Málaga-Trillo E; Reuter A; Stuermer CA Mol Biol Evol; 2011 Apr; 28(4):1363-70. PubMed ID: 21098000 [TBL] [Abstract][Full Text] [Related]
43. Two novel mammalian Nogo receptor homologs differentially expressed in the central and peripheral nervous systems. Laurén J; Airaksinen MS; Saarma M; Timmusk T Mol Cell Neurosci; 2003 Nov; 24(3):581-94. PubMed ID: 14664809 [TBL] [Abstract][Full Text] [Related]
44. Identification of MANF as a protein interacting with RTN1-C. Chen L; Wan L; Du J; Shen Y Acta Biochim Biophys Sin (Shanghai); 2015 Feb; 47(2):91-7. PubMed ID: 25543119 [TBL] [Abstract][Full Text] [Related]
45. A class of membrane proteins shaping the tubular endoplasmic reticulum. Voeltz GK; Prinz WA; Shibata Y; Rist JM; Rapoport TA Cell; 2006 Feb; 124(3):573-86. PubMed ID: 16469703 [TBL] [Abstract][Full Text] [Related]
46. Reticulon short hairpin transmembrane domains are used to shape ER tubules. Zurek N; Sparks L; Voeltz G Traffic; 2011 Jan; 12(1):28-41. PubMed ID: 20955502 [TBL] [Abstract][Full Text] [Related]
47. Widespread distribution of reticulon-3 in various neurodegenerative diseases. Heath JE; Siedlak SL; Zhu X; Lee HG; Thakur A; Yan R; Perry G; Smith MA; Castellani RJ Neuropathology; 2010 Dec; 30(6):574-9. PubMed ID: 20374499 [TBL] [Abstract][Full Text] [Related]
49. Identification and characterization of alternative promoters of zebrafish Rtn-4/Nogo genes in cultured cells and zebrafish embryos. Chen YC; Wu BK; Chu CY; Cheng CH; Han HW; Chen GD; Lee MT; Hwang PP; Kawakami K; Chang CC; Huang CJ Nucleic Acids Res; 2010 Aug; 38(14):4635-50. PubMed ID: 20378713 [TBL] [Abstract][Full Text] [Related]
50. A proteolytic C-terminal fragment of Nogo-A (reticulon-4A) is released in exosomes and potently inhibits axon regeneration. Sekine Y; Lindborg JA; Strittmatter SM J Biol Chem; 2020 Feb; 295(8):2175-2183. PubMed ID: 31748413 [TBL] [Abstract][Full Text] [Related]
51. The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases. Kulczyńska-Przybik A; Dulewicz M; Słowik A; Borawska R; Kułakowska A; Kochanowicz J; Mroczko B J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830564 [TBL] [Abstract][Full Text] [Related]
52. A novel drug target in Alzheimer's disease. Bornebroek M; Kumar-Singh S Lancet; 2004 Nov 13-19; 364(9447):1738-9. PubMed ID: 15541434 [No Abstract] [Full Text] [Related]
53. Nogo-A couples with Apg-1 through interaction and co-ordinate expression under hypoxic and oxidative stress. Kern F; Stanika RI; Sarg B; Offterdinger M; Hess D; Obermair GJ; Lindner H; Bandtlow CE; Hengst L; Schweigreiter R Biochem J; 2013 Oct; 455(2):217-27. PubMed ID: 23909438 [TBL] [Abstract][Full Text] [Related]
54. Increased expression of Noga-A in ALS muscle biopsies is not unique for this disease. Wojcik S; Engel WK; Askanas V Acta Myol; 2006 Dec; 25(3):116-8. PubMed ID: 17626519 [TBL] [Abstract][Full Text] [Related]